| A Phase I, Open-label Study to Assess Bioavailability of a Single Oral Dose of AZD9291 vs an IV Dose of [14C]AZD9291 (NCT02491944) | AstraZeneca | 2015-07-01 |
| Evaluation of Safety and Efficacy of Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma (NCT02514421) | The University of Texas Health Science Center, Houston | 2015-07-01 |
| Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD (NCT02543229) | Opthea Limited | 2015-07-01 |
| Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult and Elderly Subjects, and the Pharmacodynamics in Healthy Adult Subjects (NCT02415790) | Eisai Inc. | 2015-07-01 |
| Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease (NCT02560753) | T3D Therapeutics, Inc. | 2015-07-01 |
| The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) (NCT02500680) | Nova Immunotherapeutics Limited | 2015-07-01 |
| J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts (NCT02552394) | Weill Medical College of Cornell University | 2015-07-01 |
| Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery (NCT02496065) | Blaze Bioscience Inc. | 2015-07-01 |
| Pharmacokinetics and Safety Study of Rifamycin SV-MMX® 600 mg Tablets After Single and Multiple t.i.d. Doses in Healthy Male and Female Volunteers (NCT02969252) | Cosmo Technologies Ltd | 2015-07-01 |
| Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas (NCT02494804) | The First People's Hospital of Changzhou | 2015-07-01 |
| Safety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous Photoaging (NCT01771679) | Stemedica Cell Technologies, Inc. | 2015-07-01 |
| Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease (NCT02459886) | Biogen | 2015-07-01 |
| A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults (NCT02603055) | Jiangsu Province Centers for Disease Control and Prevention | 2015-07-01 |
| Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination (NCT02485912) | University of Oxford | 2015-07-01 |
| Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol (NCT02592096) | Lee's Pharmaceutical Limited | 2015-07-01 |
| Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillus Rhamnosus Lcr35®) on the Vaginal Flora Colonisation (NCT02730494) | Biose | 2015-07-01 |
| Open-label Study of Liothyronine in MS (NCT02506751) | Johns Hopkins University | 2015-07-01 |
| EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors (NCT01591356) | M.D. Anderson Cancer Center | 2015-07-01 |
| Effect of Luteal Progesterone Support on Pregnancy Rates With Combined Clomid/ Gonadotropin & IUI (NCT02510534) | Northwest Center for Infertility and Reproductive Endocrinology | 2015-07-01 |
| Should Colon or Non-colon Originated Lesions be Distinguished? (NCT02939508) | Chinese Medical Association | 2015-07-01 |
| Study in Postmenopausal Women to Investigate the Drug-drug Interaction (DDI) Between Itraconazole(ITZ) and Orally Administered Vilaprisan; Absolute Bioavailability Using Intravenous Microtracer Dose of [14C]Vilaprisan (NCT02456129) | Bayer | 2015-07-01 |
| Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816 (NCT02554136) | Hanmi Pharmaceutical Company Limited | 2015-07-01 |
| Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B (NCT02496897) | Altimmune, Inc. | 2015-07-01 |
| An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) (NCT02496546) | LEO Pharma | 2015-07-01 |
| Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer. (NCT02506803) | Wakayama Medical University | 2015-07-01 |
| A Safety and PK Study of EC-18 in Healthy Subjects (NCT02496143) | Enzychem Lifesciences Corporation | 2015-07-01 |
| Pilot Trial of Chlorhexidine Gluconate (CHG) Preoperative Skin Preparation (NCT02530554) | Medline Industries | 2015-07-01 |
| Single-Dose Study of a New Formulation of BIIB061 (NCT02521545) | Biogen | 2015-07-01 |
| Spreading Depolarization and Ketamine Suppression (NCT02501941) | University of New Mexico | 2015-07-01 |
| Subcutaneous Testosterone Project (NCT02229617) | University of British Columbia | 2015-07-01 |
| A Safety Study Of The Caya® Diaphragm Used With ContraGel® (NCT02462954) | CONRAD | 2015-07-01 |
| Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours (NCT02482311) | AstraZeneca | 2015-07-01 |
| A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis (NCT02464020) | University of Minnesota | 2015-07-01 |
| Effectiveness of KAE609 in Reducing Asexual & Sexual Blood-stage P.Falciparum Infection & Infectivity to Mosquitos (NCT02543086) | Novartis Pharmaceuticals | 2015-07-01 |
| Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer (NCT02483104) | AbbVie | 2015-07-01 |
| Development and Testing of an Electronic Behavioral Health Record Specific to the Wraparound Care Coordination Process (NCT02421874) | University of Washington | 2015-07-01 |
| Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients (NCT02116010) | Phagenix | 2015-07-01 |
| Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study (NCT02457351) | Bayer | 2015-07-01 |
| Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients (NCT02749019) | Peking Union Medical College Hospital | 2015-07-01 |
| Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer (NCT02654938) | Panacela Labs LLC | 2015-07-01 |
| A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization (NCT02533791) | Jiangsu Province Centers for Disease Control and Prevention | 2015-07-01 |
| Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder (NCT02537873) | Virginia Commonwealth University | 2015-07-01 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of RV6153 (NCT02517359) | Respivert Ltd | 2015-07-01 |
| Safety and Tolerability Study of MBS2320 in Healthy Subjects and Subjects With Rheumatoid Arthritis (NCT02480946) | Modern Biosciences Ltd | 2015-07-01 |
| A Bioequivalence Study of Subcutaneous (SC) Lebrikizumab Administered by Needle and Syringe or by Prefilled Syringe With Needle Safety Device (PFS-NSD) (NCT02486809) | Genentech, Inc. | 2015-07-01 |
| A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers (NCT02493738) | Boryung Pharmaceutical Co., Ltd | 2015-07-01 |
| A Water Consumption Study of ALKS 5461 in Healthy Volunteers (NCT02521857) | Alkermes, Inc. | 2015-07-01 |
| A Comparison of Controlled Ventilation With the V60 Non-Invasive Ventilator vs. Traditional Mask Ventilation (NCT02623270) | University of Utah | 2015-07-01 |
| Adipose-Derived Stromal Cells (ASC's) for Pressure Ulcers (NCT02375802) | Mayo Clinic | 2015-07-01 |
| A Single Ascending Dose Study of CD101 IV in Healthy Subjects (NCT02516904) | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-07-01 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-D4010 in Healthy Subjects (NCT02575482) | Suven Life Sciences Limited | 2015-07-01 |
| Oral Contraceptive DDI Study (NCT02494609) | Lexicon Pharmaceuticals | 2015-07-01 |
| Study of Palbociclib in MLL-rearranged Acute Leukemias (NCT02310243) | University of Ulm | 2015-07-01 |
| Diabetic Foot Ulcer Prevention System (NCT02317835) | King's College Hospital NHS Trust | 2015-07-01 |
| A Phase I/II Study to Evaluate the Safety and Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis (NCT02313883) | Geistlich Pharma AG | 2015-07-01 |
| Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older (NCT02464163) | Protein Sciences Corporation | 2015-07-01 |
| Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects (NCT02508896) | Affiris AG | 2015-07-01 |
| A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults (NCT02335164) | Vaxine Pty Ltd | 2015-07-01 |
| A Study of Cephalexin Liquid in Healthy Participants (NCT02490670) | Eli Lilly and Company | 2015-07-01 |
| A Study of Different Particle Sizes of Evacetrapib in Healthy Participants (NCT02497391) | Eli Lilly and Company | 2015-07-01 |
| Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects (NCT02411435) | ViiV Healthcare | 2015-07-01 |
| Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy (NCT02494024) | C2N Diagnostics | 2015-07-01 |
| Study of DS-7080a for the Treatment of Macular Degeneration (NCT02530918) | Daiichi Sankyo | 2015-07-01 |
| Using Ex-vivo Normothermic Machine Perfusion With the Organox Metra™ Device to Store Human Livers for Transplantation (NCT02478151) | University Health Network, Toronto | 2015-07-01 |
| Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma (NCT02504333) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2015-07-01 |
| Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer (NCT02468284) | Ferring Pharmaceuticals | 2015-07-01 |
| Pharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal Function (NCT02508506) | Alkermes, Inc. | 2015-07-01 |
| Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus (NCT02514954) | Adocia | 2015-07-01 |
| A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes (NCT02514850) | Adocia | 2015-07-01 |
| Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer (NCT02514213) | Inovio Pharmaceuticals | 2015-07-01 |
| Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery (NCT02507765) | Ohio State University Comprehensive Cancer Center | 2015-07-01 |
| Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and Pharmacodynamics (NCT02619162) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2015-07-01 |
| To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects (NCT02509923) | Zeria Pharmaceutical | 2015-07-01 |
| Study of Selinexor (KPT- 330), Lenalidomide, & Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients (NCT02389543) | Karyopharm Therapeutics Inc | 2015-07-01 |
| Simulated Amniotic Fluid Solution in Neonates Recovering From GIT Surgeries (NCT03302338) | Rania Ali El-Farrash | 2015-07-01 |
| Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC) (NCT02454478) | Eisai Co., Ltd. | 2015-07-01 |
| Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a New Formulation of Oritavancin in Healthy Volunteers (NCT02471690) | The Medicines Company | 2015-07-01 |
| Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers (NCT02506023) | Emory University | 2015-07-01 |
| Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I (NCT02371226) | ArmaGen, Inc | 2015-07-01 |
| A Study of CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT02389985) | NewLink Genetics Corporation | 2015-07-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis (NCT02531178) | AbbVie | 2015-07-01 |
| A Comparative Study of Two Endoscopic Operations for Lacrimal Duct Obstruction (NCT02636257) | Third Affiliated Hospital, Sun Yat-Sen University | 2015-07-01 |
| Study of Fasinumab (REGN475) in Healthy Japanese and Caucasian Subjects (NCT02516618) | Regeneron Pharmaceuticals | 2015-07-01 |
| A Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion on Digestive System Cancer With Ascites (NCT02530398) | Dongfang Hospital Beijing University of Chinese Medicine | 2015-07-01 |
| PK and PD Within-Subject Variability of a Single Dose of Afrezza Inhaled Technosphere Insulin in Patients With Diabetes Mellitus Type 1 (T1DM) (NCT02485327) | Mannkind Corporation | 2015-07-01 |
| Pharmacokinetics of Co-administration of Seretide 250 Diskus (HCP0910) and Spiriva Capsule for Inhalation (HGP1011) (NCT02441114) | Seoul National University Hospital | 2015-07-01 |
| Analysis of Adenosine on Sinus and Atrioventricular Nodal Conduction in the Pediatric Transplanted Heart (NCT02462941) | Columbia University | 2015-07-01 |
| Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers (NCT02712411) | Hanmi Pharmaceutical Company Limited | 2015-07-01 |
| Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042) (NCT02566252) | Pulmotect, Inc. | 2015-07-01 |
| Minocycline's Effects on Alcohol Responses in Humans (NCT02187211) | Yale University | 2015-07-01 |
| Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular Edema (NCT02485249) | Eyegate Pharmaceuticals, Inc. | 2015-07-01 |
| A Study Of PF-03084014 In Japanese Patients With Advanced Solid Tumors (NCT02462707) | Pfizer | 2015-07-01 |
| CKD-391 Pharmacokinetic Study (NCT02461004) | Chong Kun Dang Pharmaceutical | 2015-07-01 |
| Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer (NCT02499835) | University of Wisconsin, Madison | 2015-07-01 |
| Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia A (NCT02461992) | Pfizer | 2015-07-01 |
| A Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074 (NCT02511990) | Rockefeller University | 2015-07-01 |
| TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea (NCT02493530) | Vanderbilt-Ingram Cancer Center | 2015-07-01 |
| Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies (NCT02499861) | St. Justine's Hospital | 2015-07-01 |
| Study of Regorafenib and Sildenafil for Advanced Solid Tumors (NCT02466802) | Virginia Commonwealth University | 2015-07-01 |
| Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers (NCT02447367) | Jeil Pharmaceutical Co., Ltd. | 2015-07-01 |